BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 11083693)

  • 1. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
    Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
    Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
    Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
    Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
    Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D
    Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.
    Karimi A; Abolhasani M; Hashemzadeh-Chaleshtori M; Pourgheysari B
    Indian J Med Res; 2015 Jul; 142(1):46-52. PubMed ID: 26261166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
    Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
    J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Br J Haematol; 2002 Mar; 116(3):625-31. PubMed ID: 11849222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences.
    Ivanov P; Komsa-Penkova R; Kovacheva K; Ivanov Y; Stoyanova A; Ivanov I; Pavlov P; Glogovska P; Nojarov V
    Lung; 2008; 186(1):27-36. PubMed ID: 18097719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
    Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
    Rossi E; Za T; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.